JACKIE WINTER
Associate Professor
Pharmacology and Toxicology
- Associate ProfessorPharmacology and Toxicology
- 801-581-6353 (Work)
- University of Utah, Pharmacology & Toxicology, 30 South 2000 East, Salt Lake City, UT, 84112, United States
RESEARCH INTERESTS
Secondary metabolites are specialized small molecules produced in nature and often possess a variety of biological activities that can be used toward improving our quality of life. These molecules possess exquisite chemical diversity and are often an inspiration for the development of new pharmaceutical agents. Research in the Winter lab is focused on 1) Elucidating the biosynthetic blueprint that nature uses for assembling secondary metabolites in bacteria and fungi, 2) Manipulating and reprograming biosynthetic systems for the generation of new compounds with enhanced bioactivity, and 3) Exploring the functional roles these molecules serve the producing organism, as well as their impact on the environment. To address these topics, we apply a multifaceted approach in our studies and implement research techniques from molecular genetics, biochemistry, chemistry, bioinformatics, structural biology and bioengineering.
Discovery and development of antibiotic agents
As secondary metabolites continue to be an inspiration for drug discovery programs, new chemical entities and molecules possessing novel modes of action are in high demand. Biological pressures can influence the chemical diversity of secondary metabolites, and microorganisms residing in extreme or chemically unique environments often produce molecules not observed in their terrestrial counterparts. These microorganisms serve as an ideal resource for drug discovery efforts and for the characterization of novel biosynthetic enzymes. We therefore prioritize microorganisms inhabiting marine and hypersaline ecosystems, where strong selective pressures drive the evolution of chemically and biosynthetically distinct secondary metabolites. By identifying the corresponding biosynthetic clusters, we can 1) Interrogate the strategies that nature uses for synthesizing and installing unique functional groups responsible for the observed biological activity and 2) Use this information to incorporate new chemical features into existing molecular scaffolds and enhance their inherent biological activities.
Combinatorial biosynthesis
In their host organisms, secondary metabolites are assembled and modified by specialized machinery. Often times, the complex structures or chemical modifications instated by these molecular assembly lines are difficult to replicate using traditional synthetic methods, which pose significant challenges when developing pharmaceutical agents or derivatives for testing in biological assays. We aim to develop alternative approaches for producing these otherwise inaccessible molecules or derivatives by 1) Reprogramming the biosynthetic machinery for the production of therapeutic agents with increased biological activities and 2) Develop the individual enzymes that carry out complicated reactions into renewable and environmentally friendly biocatalysts for the chemoenzymatic synthesis or derivatization of new chemical entities.
Metal-Driven Microbial Adaptation and Resistance
In addition to discovering biologically active secondary metabolites, we study how microorganisms adapt to metal-rich and chemically extreme environments. These habitats are characterized by elevated heavy metal concentrations that impose strong selective pressures on resident microbial communities, shaping both community structure and metabolic potential. Our work focuses on identifying metallophores and other small molecules involved in metal acquisition, sequestration, and detoxification. Using integrated metagenomic, genomic, metabolomic, and biochemical approaches, we examine how metal stress influences microbial community composition and function. Because metal stress and antibiotic resistance are often mechanistically linked, we also explore how metal-adaptive pathways intersect with antimicrobial resistance and survival under chemical stress. Together, these studies provide insight into the chemical and genetic foundations of microbial resilience and reveal new opportunities for therapeutic and biotechnological discovery.
GRANTS
- EXTERNAL GRANT OR CONTRACTGENOMICS-ASSISTED ANTIBIOTIC DISCOVERY FROM UNPRECEDENTED MICROBES OF THE GREAT SALT LAKE12 Jul 2021 - 30 Apr 2027
- EXTERNAL GRANT OR CONTRACTANTIBIOTIC DISCOVERYAMERICAN SOCIETY OF PHARMACOGN8 Jan 2017 - 31 Dec 2018
- EXTERNAL GRANT OR CONTRACTDISCOVERING ANTI-CANCER AGENTSUNIVERSITY OF COLORADO AT DENV7 Jan 2017 - 31 Dec 2019